Skip to main content

Table 2 The results of CAG in the study patients

From: Evaluation of the prevalence of coronary artery disease in patients with valvular heart disease

  MS (MVR) (n=72) MR (MVR) (n=93) AS (AVR) (n=40) AR (AVR) (n=36) P value
Presence of CAD* 19 (26.4%) 39 (42%) 23 (57.5%) 16 (44.4%) 0.01
Gensini score** 2.97±8.75 11.02±25.26 11.20±28.26 7.55±16.98 0.077
CABG (%) 6 (8.3%) 12 (12.9%) 10 (25%) 6 (16.7%) 0.102
LVEF (%) 54.93±7.45 50.29±12.05 53.12±10.30 50.25±13.07 0.03
  1. CAG, Coronary artery angiography; MS, mitral stenosis; MR, mitral regurgitation; MVR, mitral valve replacement; AS, aortic stenosis; AR, aortic regurgitation; AVR, aortic valve replacement. CAD, Coronary artery disease; CABG, Coronary artery bypass graft; LVEF, Left ventricular ejection fraction.
  2. *The prevalence of CAD was significantly higher in AS group compared to MS group (p=0.002). The prevalence of CAD was significantly higher in MR group compared to MS group (p=0.02).
  3. **The Gensini score was significantly higher in MR group compared to MS group (p=0.005).
Back to article page